Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Subjects:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

A sample choice question without a warning label. by Yulian Ding (5984591)

“…The random parameters logit model results showed a significant overall decrease in SSB purchases when a warning label was present, indicated by a significant negative coefficient associated with the label. …”

Event-free survival analysis of microvascular outcome. by Clemens Plattner (21567706)

Subjects:

Event-free survival analysis of macrovascular outcome. by Clemens Plattner (21567706)

Subjects:

Clinical characteristics. by Clemens Plattner (21567706)

Subjects:

Insulin-free survival in patients with and without FHD. by Clemens Plattner (21567706)

Subjects:

Proteomic and Transcriptomic Profiling Revealed Vital Molecular Events in the Transition from Goat Colostrum to Mature Milk by Xiao Zhang (152326)

Subjects:

Cascade of care by HCV testing model. by Bao Vu Ngoc (14551955)

Subjects:

Factors associated with first-time HCV testing. by Bao Vu Ngoc (14551955)

Subjects:

Optimal proportion under comprehensive balance analysis (vertical "*" indicates the number of occurrences for a certain factor at a certain level, horizontal "*" denotes the degree... by Junxia Zhou (14381598)

The ATR-CHK1 inhibitor AZD6738 decreases HBV cccDNA level. by Kaitao Zhao (3617825)

Enrichment analysis of genes from the significant MS module. by Lai Jiang (2401513)

“…<p><b>(a)</b> Venn diagram showing the intersection of DEGs and significant module genes from WGCNA, resulting in 46 key intersection genes. …”

GPT-4 results in decreased error rate for all tasks with increasing complexity when compared to GPT-3.5-turbo. by Jacqueline A. Jansen (14894276)

NMR aperture distribution of samples before and after 100 FTCs under three curing conditions: (a) standard curing; (b) 5 °C curing; (c) −3 °C curing. by YongHe Liu (20477123)

Subjects: